Keeping Up with Cardiology

• Series Overview
• Program Content
• Faculty
• Target Audience and Learning Objectives
• CPE Credit
• BCACP Specialty Recertification Credit
• Technical Requirements
• Fees

Clinical Reasoning Series is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

“Keeping Up with Cardiology” will provide an in-depth analysis of current strategies for the management of patients with cardiovascular conditions, as well as discuss the implications for pharmacists’ patient care services.

“Keeping Up with Cardiology” covers the following content:

• Heart Failure’s Role in Medication Selection
• Atrial Fibrillation: Medical Management with Anticoagulation and Beyond
• Dyslipidemia: Whose Side Are You On?
• Hypertension Targets, Medication Use and Special Populations
• Practice Management in Cardiology: Integrating Pharmacists into Ambulatory Care Clinics

	Kirk E. Evoy, Pharm.D., BCACP, BC-ADM, CTTS Clinical Assistant Professor and Ambulatory Care Pharmacist University of Texas at Austin and University Health System San Antonio, Texas
	Liza Renner, Pharm.D., BCPS, BCACP, CACP Clinical Pharmacist Specialist Michigan Medicine Ann Arbor, Michigan
	Jessica Wilhoite, Pharm.D., BCACP Associate Professor of Pharmacy Practice Butler University College of Pharmacy and Health Sciences Ambulatory Care Pharmacy Manager, Community Health Network Indianapolis, Indiana

Clinical Pharmacists and BCACPs providing care to patients with cardiovascular conditions.

At the conclusion of the program, the participant should be able to:

1. Recognize the impact of heart failure on medication selection for treatment of co-morbid disease states.
2. Dritically evaluate national guidelines and current primary literature to develop patient-specific treatment plans for the management of heart failure, atrial fibrillation, dyslipidemia and hypertension.
3. Recommend optimal treatment targets for heart failure, atrial fibrillation, dyslipidemia and hypertension in specific patient populations.
4. Identify opportunities to optimize ambulatory care pharmacy services in cardiovascular care areas.

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based activity; Activity Number: 0217-0000-17-164-H01-P.

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 10, 2020. Partial credit is not available for this activity.

To be eligible for 6.0 CPE hours of recertification credit, BCACPs must successfully complete a Web-based posttest by December 31, 2017. Partial credit is not available for this activity.

ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.

Requires an Internet browser and Adobe Reader.